MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 27, 2006; DOI: 10.1124/mol.105.021220


0026-895X/06/6906-1924-1930$20.00
Mol Pharmacol 69:1924-1930, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.021220v1
69/6/1924    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueda, R.
Right arrow Articles by Yamazoe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueda, R.
Right arrow Articles by Yamazoe, Y.

A Common Regulatory Region Functions Bidirectionally in Transcriptional Activation of the Human CYP1A1 and CYP1A2 Genes

Rika Ueda, Hiromi Iketaki, Kiyoshi Nagata, Shioko Kimura, Frank J. Gonzalez, Kazutomi Kusano, Tsutomu Yoshimura, and Yasushi Yamazoe

Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (R.U., H.I., K.N., Y.Y.); Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation, Tohoku University 21st Century "Center of Excellence" Program (Y.Y.), Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (S.K., F.J.G.); and Drug Metabolism and Pharmacokinetics Research, Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan (R.U., K.K., T.Y.)

The human CYP1A1 and CYP1A2 genes on chromosome 15 are orientated head-to-head and are separated by a 23-kilobase (kb) intergenic spacer region. Thus, the possibility exists for sharing common regulatory elements contained in the spacer region responsible for transcriptional activation and regulation of the CYP1A1 and CYP1A2 genes. In the present study, a reporter gene construct containing -22.4 kb of the 5'-flanking region of the CYP1A2 gene was found to support beta-naphthoflavone (BNF) and 3-methylchoranthrene (3-MC)-mediated transcriptional activation. The responsive region was also functional in directing activation of the CYP1A1 promoter, indicating that the region works bidirectionally to govern transcriptional activation of both CYP1A1 and CYP1A2. To simultaneously evaluate transcriptional activation of both genes, a dual reporter vector was developed in which the spacer region was inserted between two different reporter genes, firefly luciferase and secreted alkaline phosphatase. Transient transfection of the dual reporter vector in HepG2 cells revealed increases in both reporter activities after exposure of the cells to BNF and 3-MC. Deletion studies of the spacer region indicated that a region from -464 to -1829 of the CYP1A1 gene works bidirectionally to enhance the transcriptional activation of not only CYP1A1 but also CYP1A2. In addition, a negative bidirectional regulatory region was found to exist from -18,989 to -21,992 of the CYP1A1 gene. These data established that induction of human CYP1A1 and CYP1A2 is simultaneously controlled through bidirectional and common regulatory elements.


Received November 28, 2005; accepted February 27, 2006

Address correspondence to: Dr. Kiyoshi Nagata, Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aramaki-Aoba 6-3, Aoba-ku, Sendai, 980-8578, Japan. E-mail: nagataki{at}mail.tains.tohoku.ac.jp




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. Healan-Greenberg, J. F. Waring, D. J. Kempf, E. A. G. Blomme, R. G. Tirona, and R. B. Kim
A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor
Drug Metab. Dispos., March 1, 2008; 36(3): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. T. Okino, L. C. Quattrochi, D. Pookot, M. Iwahashi, and R. Dahiya
A Dioxin-Responsive Enhancer 3' of the Human CYP1A2 Gene
Mol. Pharmacol., December 1, 2007; 72(6): 1457 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Ihalmo, H. Schmid, M. P. Rastaldi, D. Mattinzoli, R. G. Langham, P. Luimula, R. Kilpikari, M. Lassila, R. E. Gilbert, D. Kerjaschki, et al.
Expression of filtrin in human glomerular diseases
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1903 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. P. Martinez-Jimenez, J. V. Castell, M. J. Gomez-Lechon, and R. Jover
Transcriptional Activation of CYP2C9, CYP1A1, and CYP1A2 by Hepatocyte Nuclear Factor 4{alpha} Requires Coactivators Peroxisomal Proliferator Activated Receptor-{gamma} Coactivator 1{alpha} and Steroid Receptor Coactivator 1
Mol. Pharmacol., November 1, 2006; 70(5): 1681 - 1692.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics